Armata Pharmaceuticals, Inc.
ARMP- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000921114
No open-market purchases or sales by Armata Pharmaceuticals, Inc. insiders were filed in the last 90 days; 53 institutions reported holding it in 13F filings for Q2 2026, worth $32.3M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Armata Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 20 | 17 | −3 |
| Shares | 1.19M | 1.32M | +129.9K (+10.9%) |
| Value | $4.32M | $7.25M | +$2.93M (+67.9%) |
New holders (2)
Institutions that held Armata Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dimensional Fund Advisors LP | 13,072 | $72.0K | 0.00% |
| Susquehanna International Group, LLP | 12,032 | $66.0K | 0.00% |
Sold out (5)
Institutions that held Armata Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Citadel Advisors LLC | 11,783 | $43.0K |
| Sandy Spring Bank | 1,082 | $4.00K |
| Tower Research Capital LLC (TRC) | 866 | $3.00K |
| Harbour Investments, Inc. | 21 | $0 |
| TCI Wealth Advisors, Inc. | 100 | $0 |